Prenatal DNA test may uncover Mom's cancer risk

NCT ID NCT04049604

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at pregnant women whose routine blood tests for the baby's DNA came back unusual or unclear. Researchers want to find out if these results can signal cancer in the mother. Participants will have imaging, lab tests, and surveys, and may be followed for up to 5 years. The goal is to better understand the link between these test results and cancer, not to provide a direct treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MATERNAL NEOPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States